Senseonics Holdings, Inc. (SENS) is a Medical - Devices company in the Healthcare sector, currently trading at $6.75. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is SENS = $9 (+33.3% upside).
Valuation: SENS trades at a trailing Price-to-Earnings (P/E) of -4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.41.
Financials: revenue is $35M, +31.3%/yr average growth. Net income is $69M (loss), growing at -53.5%/yr. Net profit margin is -196% (negative). Gross margin is 44.7% (+28.1 pp trend).
Balance sheet: total debt is $41M against $61M equity (Debt-to-Equity (D/E) ratio 0.68, moderate). Current ratio is 4.83 (strong liquidity). Debt-to-assets is 32.8%. Total assets: $126M.
Analyst outlook: 9 / 16 analysts rate SENS as buy (56%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 84/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 50/100 (Partial), Moat 43/100 (Fail), Future 64/100 (Pass), Income 10/100 (Fail).
